Bruce Smith

Halifax, NS, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420.

A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420.

Journal: medRxiv : the preprint server for health sciences

Published: June 29, 2026

Development and validation of super learner models to predict small and large for gestational age in the second generation.

Development and validation of super learner models to predict small and large for gestational age in the second generation.

Journal: Scientific reports

Published: June 16, 2025

Grandmaternal prepregnancy body mass index and infant birthweight: a mediation analysis of maternal prepregnancy body mass index.

Grandmaternal prepregnancy body mass index and infant birthweight: a mediation analysis of maternal prepregnancy body mass index.

Journal: American journal of epidemiology

Published: September 21, 2023

An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) study.

An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) study.

Journal: Vaccine

Published: August 14, 2023

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.

Journal: Lancet (London, England)

Published: October 19, 2021

Using principal component analysis to investigate pacing strategies in elite international canoe kayak sprint races.

Using principal component analysis to investigate pacing strategies in elite international canoe kayak sprint races.

Journal: Sports biomechanics

Published: August 27, 2020

Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial.

Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial.

Journal: The Lancet. Infectious diseases

Published: June 22, 2020

Vaccine coverage among children with epilepsy in two Canadian provinces: A Canadian immunization research network study.

Vaccine coverage among children with epilepsy in two Canadian provinces: A Canadian immunization research network study.

Journal: Vaccine

Published: June 15, 2020

Adverse Events Following Immunization Among Children With Epilepsy: A Self-Controlled Case Series.

Adverse Events Following Immunization Among Children With Epilepsy: A Self-Controlled Case Series.

Journal: The Pediatric infectious disease journal

Published: April 18, 2020

A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response.

A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: November 21, 2017

Risk of seizures after immunization in children with epilepsy: a risk interval analysis.

Risk of seizures after immunization in children with epilepsy: a risk interval analysis.

Journal: BMC pediatrics

Published: August 29, 2017

Reply to Weber, von Cube, Sommer, Wolkewitz: Necessity of a Competing Risk Approach in Risk Factor Analysis of Central-Line-Associated Bloodstream Infection.

Reply to Weber, von Cube, Sommer, Wolkewitz: Necessity of a Competing Risk Approach in Risk Factor Analysis of Central-Line-Associated Bloodstream Infection.

Journal: Infection control and hospital epidemiology

Published: February 01, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026